SHILPA MEDICARE LTD. - 530549 - Shareholding for the Period Ended June 30, 2019
Shilpa Medicare Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2019. For more details, kindly Click here20-07-2019
20-07-2019
Shilpa Medicare Ltd - 530549 - Statement Of Investor Complaints For The Quarter Ended June 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0431 Name of the Signatory :- SUSHIL BAJAJDesignation :- Authorised Signatory19-07-2019
SHILPA MEDICARE LTD. - 530549 - Closure of Trading Window
With reference to the above it is informed hereby that the trading window will remain closed for dealing in the securities of the Company for all Designated Employees/ Persons and their immediate relatives with effect from 01st July, 2019 till the end of 48 hours from the declaration of the financial results for the quarter ended 30th June, 2019.28-06-2019
SHILPA MEDICARE LTD. - 530549 - Compliance Under Regulation 23(9) Of SEBI (Listing Obligation And Disclosure Requirement) Regulation 2015
With reference to regulation 23(9) of the SEBI (Listing Obligation and Disclosure Requirement) Regulation 2015 please find enclosed herewith the related party transactions on consolidated basis in format as per the accounting standard for the half year ended 31.03.2019.25-06-2019
Shilpa Medicare Ltd - 530549 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vishnukant Chaturbhuj Bhutada11-06-2019
Shilpa Medicare Ltd - 530549 - Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report Sr. No. Particulars Details 1Period for which the report has been issued 31/03/2019 2Date of Report30/05/2019 3 Name of the Certifying Firm PSRAO&ASSOCIATES; 4 Name of the Certifying Individual DS RAO 5Membership TypeACS 6 Membership Number 12394 7 CP No. 14487 8 Whether any observations/qualification reported by the Secretarial Auditor ? Yes30-05-2019
Shilpa Medicare Ltd - 530549 - Announcement under Regulation 30 (LODR)-Cessation
With reference to the above-cited subject, we wish to inform you that Ms. Namrata Bhutada (DIN: 05l336l4), Director of the Company, has submitted her resignation due to her personal reasons and the same has been accepted by the Board of Directors with effect from 27th May, 20l9. She has been on the Board since 28lh February, 2015.28-05-2019
SHILPA MEDICARE LTD. - 530549 - Board recommends Dividend
Shilpa Medicare Ltd has informed BSE that the Board of Directors of the Company at its Meeting held on May 27, 2019, inter alia, has recommended Dividend of 100% (i.e. Re. 1/- per every share of face value of Re. 1) for the financial year 2018-19 subject to approval of members.27-05-2019
SHILPA MEDICARE LTD. - 530549 - Announcement under Regulation 30 (LODR)-Dividend Updates
The board of directors of Shilpa Medicare Limited Recommend Dividend of 100% (ire. Re l/- per every share of face value of Rel) for financial year 2018-19 subject to approval of members27-05-2019
SHILPA MEDICARE LTD. - 530549 - Results For Year Ended 31-03-2019
Audited Standalone and Consolidated Financial Statements for the Financial Year ended 31' March, 2019' Auditors' Report for the Financial Year ended 31S/ March, 2019' Recommend Dividend of 100% (ire. Rel/- per every share of face value of Rel) for financial year 2018-19 subject to approval of members, To foray into the R&D; activities of specific drug processes by roping prominent technocrats through a new subsidiary company incorporated as Sravathi Advance Process Technologies Private Limited. The resignation tendered by Ms. Namrata Bhutada with effect from 27052019.27-05-2019